Skip to main content
. 2019 May 11;11(5):229. doi: 10.3390/pharmaceutics11050229

Figure 4.

Figure 4

Serum norovirus (NoV)-specific cross-reactive IgG antibodies. Pooled termination sera of experimental groups receiving 0.3 µg NoV GI.4 and GII.4-2006a VLPs alone or mixed with 10 µg of RV VP6 were diluted 1:200 and tested for cross-reactive IgG against two NoV (A) GI VLPs and (B) four GII VLPs. Control (Ctrl) mice received carrier only (PBS). Mean OD values with the standard errors are shown for replicate analysis.